Law360, New York (April 22, 2011, 5:30 PM ET) -- Two medical studies published Thursday found that women taking drospirenone-containing birth control pills such as Bayer HealthCare Pharmaceuticals Inc.'s Yasmin and Yaz could be at higher risk of blood clots than those taking oral contraceptives with a different progestin hormone.
The studies in the British Medical Journal, which involved U.S. and U.K. women who used oral contraceptives containing drospirenone or levonorgestrel, come amid a flood of personal injury and wrongful death lawsuits against Bayer over the safety of its popular birth control pills and whether company...
Yaz, Similar Pills Tied To Higher Blood Clot Risks
To view the full article, take a free trial now.
